Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Heart rhythm and blood flow changes during pregnancy and after birth

Official title: Cardiovascular Research in EMbarazo and MAternity (EMMA). Study on Heart Rate Variability and Hemodynamic Adaptations During Pregnancy and Postpartum.

Run by Fundacin Biomedica Galicia Sur · NCT07376616 · Data updated 2026-11-12

This project will test whether measuring heart rate variability and blood pressure can track heart and circulation changes in pregnant people from the third month through the postpartum period.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment242 (estimated)
SponsorFundacin Biomedica Galicia Sur
Academic / other
Locations1 site (Vigo, Pontevedra)
StatusRecruiting
StartedMay 19, 2025
Main results expectedDecember 15, 2027
Study endsDecember 15, 2027
Registry record updatedFebruary 17, 2026
Trial IDNCT07376616 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who are pregnant from at least the third month of gestation, have no pre-existing cardiovascular disease, and can give informed consent are ideal candidates.

Probably not a fit

People with exclusions such as diabetes, chronic hypertension before pregnancy, thyroid disease, significant cardiac conditions, chronic kidney disease, major neurological disorders, or other listed conditions are not eligible and would likely not benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study that uses non-invasive measurements of heart rate variability (HRV) and blood pressure to document cardiovascular and autonomic changes during pregnancy and after delivery. Participants are enrolled from the third month of gestation and followed through the postpartum period with periodic monitoring visits. The study will correlate HRV measures with hemodynamic data to characterize normal adaptation and to explore patterns linked to complications. No experimental treatments are given; the focus is on measurement and pattern recognition.

Why it matters

Potential benefit: If successful, these measurements could provide a simple, non-invasive way to monitor maternal cardiovascular health and help identify pregnancies at higher risk of complications earlier.

How similar studies have gone: Previous observational studies have shown pregnancy-related shifts in HRV and hemodynamics, but using these measures to reliably predict complications remains limited and is still being researched.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over 18 years of age
* Pregnancy from the third month of gestation
* No pre-existing cardiovascular disease
* Good cognitive level
* Sign informed consent

Exclusion Criteria:

* Diabetes mellitus
* Hyperthyroidism
* Hypothyroidism
* Chronic hypertension diagnosed before pregnancy
* Heart failure
* Ischemic heart disease or malignant ventricular arrhythmias (ventricular fibrillation, ventricular tachycardia, grade 2 or 3 AV block, atrial fibrillation in patients with Wolff-Parkinson- White syndrome, paroxysmal fibrillation or flutter with rapid ventricular response and hemodynamic deterioration, uncontrolled supraventricular tachycardia)
* Exercise-induced ischaemia
* Unstable angina
* Disease not susceptible to revascularization
* Associated valvular heart disease
* Chronic kidney disease
* Degenerative neurological condition
* Brain aneurysms
* Arteriovenous malformations
* History of transient cerebral infarction (ICTUS)
* Migraines diagnosed
* Epilepsy
* Brain or spinal cord injury
* Tumors
* Diseases of the respiratory tract
* Diseases of lung tissue
* Diseases of pulmonary circulation

Where it's running

  • Hospital Alvaro Cunqueiro
    Vigo, Pontevedra, Spain
    Recruiting

Study contacts

  • Principal investigator: Alicia González Represas — Instituto de Investigación Sanitaria Galicia Sur (IISGS)
  • Study coordinator: Alicia González Represas
  • Email: alicia@uvigo.gal
  • Phone: 616044977

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.